Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Evaluation of the New Minion Chemistry and Duplex Basecalling for Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia

Jordi Martinez-Serra, Julieta Nastasi, Blanca Ferrer Lores, Alicia Serrano-Alcalá, Adrian Moquera, Antonia Sampol Mayol, Maria Jose Terol Castera, Antonio Gutiérrez

Blood (2024) 144 (Supplement 1): 6765.

https://doi.org/10.1182/blood-2024-211399

Published: 2024

Journal Articles

In Vitro Validation of Micro-RNAs (miRNAs) Associated to Treatment Failure in Diffuse Large B-Cell Lymphoma (DLBCL)

Adriana Sas, Leyre Bento, Josep Muncunill, Jordi Martínez-Serra, Teresa Ros, Víctor Asensio, Oliver Vögler, Antonio Salar, MD PhD, Antonia Sampol, MD, Regina Alemany, Antonio Gutierrez

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-141765

Published: 2020

Journal Articles

Analysis of Micro-RNAs Associated to Treatment Failure in Diffuse Large B Cell Lymphoma

Blood (2019) 134 (Supplement_1): 1627.

https://doi.org/10.1182/blood-2019-130544

Published: 2019

Journal Articles

New Prognosis Score Including Absolute Lymphocytes/Monocytes Ratio and Beta2microglobulin in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)

Blood (2018) 132 (Supplement 1): 347.

https://doi.org/10.1182/blood-2018-99-118719

Published: 2018

Journal Articles

Long Term Follow-up in Mantle Cell Lymphoma Patients Treated with R-GemOx Followed By Consolidation and Rituximab Maintenance

Marta Garcia Recio, Leyre Bento, MD, Sandra Pérez-León, Sara Aida Jiménez-Julià, Jordi Gines, Jordi Martínez-Serra, PhD, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 5337.

https://doi.org/10.1182/blood-2018-99-119713

Published: 2018

Journal Articles

Identification of Patients with Follicular Lymphoma Patients at Risk of Failing Frontline Immunochemotherapy and Rituximab Maintenance

Marta Garcia Recio, Sandra Pérez-León, Leyre Bento, MD, Antonio Salar, MD PhD, Blanca Sanchez-Gonzalez, Jordi Gines, Beatriz Robredo, Lucia García, Sara Aida Jiménez-Julià, Jordi Martínez-Serra, PhD, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 5339.

https://doi.org/10.1182/blood-2018-99-119551

Published: 2018

Journal Articles

R-CHOP with or without Lenalidomide/Bortezomib As a First Line Treatment for Patients with Non-Germinal Center Diffuse Large B Cell Lymphoma (DLBCL) Subtype: Son Espases University Hospital Experience

Sara Aida Jiménez-Julià, Leyre Bento, MD, Adriana Marcela Quintero, Marta Garcia Recio, Jordi Martínez-Serra, PhD, Francesc Mestre, Lucia García, Sandra Pérez, Gaspar Aspas, Paloma López Perezagua, Jaume Daumal, Rafael Ramos, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 1710.

https://doi.org/10.1182/blood-2018-99-119138

Published: 2018

Journal Articles

Red Cell Distribution Width (RDW) at Diagnosis of Diffuse Large B-Cell Lymphoma (DLBCL) Is Associated to Higher Mortality and Worse Overall Survival

Leyre Bento, MD, Juan Sarmentero, MD, Ana Ortuño, MD, Marta García-Recio, MD, Bernardo Lopez, Jordi Martínez-Serra, PhD, Jose Rodriguez, MD PhD, Antonia Sampol, Antonio Gutierrez, MD PhD

Blood (2016) 128 (22): 5398.

https://doi.org/10.1182/blood.V128.22.5398.5398

Published: 2016

Journal Articles

Hypogammaglobulinaemia and Infectious Toxicity Related with the Use of Maintenance Strategies with Rituximab in B Lymphomas

Lucia García Mañó, MD, Leyre Bento, MD, Jordi Martinez-Serra, Antonio Salar, MD PhD, Jose Maria Sanchez Raga, Inés Herráez, MD, Silvia Ruiz-de Gracia, MD, Marta García-Recio, MD, Mariana Ferraro, Francesc Garcia, Juan Besalduch, Antonia Sampol, Antonio Gutierrez, MD PhD

Blood (2015) 126 (23): 5100.

https://doi.org/10.1182/blood.V126.23.5100.5100

Published: 2015

Journal Articles

Addition of Absolute Lymphocytes/Monocytes Ratio Improves the Revised-International Prognostic Index (R-IPI) in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Leyre Bento, MD, Antonia María Bautista-Gili, MD, Francesc García, Jordi Martínez-Serra, PhD, Lucía García-Mañó, MD, Marta García-Recio, MD, Carmen Ballester, MD, Jordi Ginés, MD, Paloma López, MD, Jaime Daumal, Rafael Ramos, MD, Antonio Salar, MD PhD, Antonia Sampol, MD PhD, Juan Besalduch, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2015) 126 (23): 2654.

https://doi.org/10.1182/blood.V126.23.2654.2654

Published: 2015

Journal Articles

Differential Impact of Relative Dose-Intensity Reductions (DIR) in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP21 or R-CHOP14

Leyre Bento, MD, Francesc Garcia, PhD, Antonia Maria Bautista-Gili, Blanca Sanchez, Lucia Garcia, MD, Eva Gimeno, Jordi Martinez-serra, PhD, Mariana Ferraro, Raquel Del campo, Javier Vercher, Miguel Scaff, Ana Pacheco, Florencia Garcia, Rafael Ramos, MD, Carmen Ballester, Juan Besalduch, MD PhD, Joan Bargay, MD, Antonio Salar, MD, Antonio Gutierrez, MD PhD

Blood (2014) 124 (21): 3073.

https://doi.org/10.1182/blood.V124.21.3073.3073

Published: 2014

Journal Articles

Impact Of Dose-Density Delays In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-CHOP21 Or R-CHOP14

Antonio Gutierrez, MD, PhD, Antonia M Bautista-Gili, MD, Leyre Bento, MD, Ines Herraez, MD, Lucia Garcia, MD, Jordi Martinez-serra, PhD, Antonia Sampol, MD, PhD, Rafael Ramos, MD, Jordi Gines, MD, Carmen Ballester, MD, Albert Perez, MD, Paloma Lopez-Perezagua, MD, Jaime Daumal, MD, Jose Rodriguez, MD, PhD, Juan Besalduch, MD, PhD

Blood (2013) 122 (21): 4374.

https://doi.org/10.1182/blood.V122.21.4374.4374

Published: 2013

Journal Articles

Radiotherapy Overcomes Adverse Prognostic Role Of COX-2 Expression On Reed-Sternberg Cells In Early Hodgkin Lymphoma

Antonio Gutierrez, MD, PhD, Mestre Francesc, MD, Jose Rodriguez, MD, PhD, Jordi Martinez-serra, PhD, Rafael Ramos, MD, Ines Herraez, MD, Antonia M Bautista-Gili, MD, Leyre Bento, MD, Lucia Garcia, MD, Jordi Gines, MD, Teresa Ros, Albert Perez, MD, Paloma Lopez-Perezagua, MD, Jaime Daumal, MD, Juan Besalduch, MD, PhD

Blood (2013) 122 (21): 1757.

https://doi.org/10.1182/blood.V122.21.1757.1757

Published: 2013

Journal Articles

Gemcitabine and Oxaliplatinum (GemOx): An Effective Regimen in Patients with Refractory and Relapsing Hodgkin Lymphoma

Antonio Gutierrez, MD, PhD, Jose Rodriguez, Andres Lopez, Jordi Martinez-serra, Jorge Gines, María Pilar Paredes, Florencia Garcia, Javier Vercher, Josep Balanzat, Raquel Del campo, Pilar Galan, Miguel Morey, Joan Bargay, Juan Besalduch, MD, PhD

Blood (2012) 120 (21): 4845.

https://doi.org/10.1182/blood.V120.21.4845.4845

Published: 2012

Journal Articles

Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD

Francisco Mestre, Antonio Gutierrez, Rafael Ramos, Jordi Martinez-Serra, Lydia Sánchez, Gabriel Matheu, Teresa Ros, Juan Fernando Garcia, Jose Rodriguez

Blood (2012) 119 (25): 6072–6079.

https://doi.org/10.1182/blood-2011-11-394627

Published: 2012

Includes: Supplemental data

Journal Articles

Expression of COX-2 Is An Independent Unfavourable Prognostic Factor in Hodgkin Lymphoma Treated with ABVD with or without Radiotherapy.

Francisco Mestre, Antonio Gutierrez, MD, Rafael Ramos, Jordi Martinez-Serra, Antonia Bautista, José Fuster, Pilar Lopez-Marti, Marta Casasus, Cristina Nicolau, Julio Rifa, Juan Besalduch, MD, Juan Fernando Garcia, Jose Rodriguez

Blood (2009) 114 (22): 1560.

https://doi.org/10.1182/blood.V114.22.1560.1560

Published: 2009

Journal Articles

Vascular Endothelial Growth Factor (VEGF) Expression by Neoplastic Hodgkin-Reed-Sternberg Cells Is An Independent Adverse Prognostic Factor for Relapse in Hodgkin Lymphoma.

Antonio Gutierrez, MD, Francisco Mestre, Rafael Ramos, Jordi Martinez-Serra, Antonia Bautista, José Fuster, Pilar Lopez-Marti, Marta Casasus, Cristina Nicolau, Julio Rifa, Joan Besalduch, Juan Fernando Garcia, Jose Rodriguez

Blood (2009) 114 (22): 1561.

https://doi.org/10.1182/blood.V114.22.1561.1561

Published: 2009

NARROW

Evaluation of the New Minion Chemistry and Duplex Basecalling for Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia

In Vitro Validation of Micro-RNAs (miRNAs) Associated to Treatment Failure in Diffuse Large B-Cell Lymphoma (DLBCL)

Analysis of Micro-RNAs Associated to Treatment Failure in Diffuse Large B Cell Lymphoma

New Prognosis Score Including Absolute Lymphocytes/Monocytes Ratio and Beta2microglobulin in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)

Long Term Follow-up in Mantle Cell Lymphoma Patients Treated with R-GemOx Followed By Consolidation and Rituximab Maintenance

Identification of Patients with Follicular Lymphoma Patients at Risk of Failing Frontline Immunochemotherapy and Rituximab Maintenance

R-CHOP with or without Lenalidomide/Bortezomib As a First Line Treatment for Patients with Non-Germinal Center Diffuse Large B Cell Lymphoma (DLBCL) Subtype: Son Espases University Hospital Experience

Red Cell Distribution Width (RDW) at Diagnosis of Diffuse Large B-Cell Lymphoma (DLBCL) Is Associated to Higher Mortality and Worse Overall Survival

Hypogammaglobulinaemia and Infectious Toxicity Related with the Use of Maintenance Strategies with Rituximab in B Lymphomas

Addition of Absolute Lymphocytes/Monocytes Ratio Improves the Revised-International Prognostic Index (R-IPI) in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Differential Impact of Relative Dose-Intensity Reductions (DIR) in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP21 or R-CHOP14

Impact Of Dose-Density Delays In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-CHOP21 Or R-CHOP14

Radiotherapy Overcomes Adverse Prognostic Role Of COX-2 Expression On Reed-Sternberg Cells In Early Hodgkin Lymphoma

Gemcitabine and Oxaliplatinum (GemOx): An Effective Regimen in Patients with Refractory and Relapsing Hodgkin Lymphoma

Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD

Expression of COX-2 Is An Independent Unfavourable Prognostic Factor in Hodgkin Lymphoma Treated with ABVD with or without Radiotherapy.

Vascular Endothelial Growth Factor (VEGF) Expression by Neoplastic Hodgkin-Reed-Sternberg Cells Is An Independent Adverse Prognostic Factor for Relapse in Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only